Thomas Holm Pedersen - Crunchbase Person Profile
Management — NMD Pharma
Annual Report 2018 by Lundbeckfonden - issuu
Management — NMD Pharma
Company Presentation
Management — NMD Pharma
Redalyc.Endocrine disruptors: strategies for determination and occurrence in marine environments
Rare Neuromuscular Disease Company NMD Pharma Raises USD 3 Million in Seed Financing Round - Lundbeckfonden
65% 460 175+ 150+
Company Presentation
Management — NMD Pharma
PDF) Perceptions of gender equity in departmental leadership, research opportunities, and clinical work attitudes: an international survey of 11 781 anaesthesiologists
Agenda - Neurotech Partnering
65% 460 175+ 150+
Company Presentation
Management — NMD Pharma
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
Annual Report 2016 by Lundbeckfonden - issuu
Management — NMD Pharma
Thomas H. Pedersen - CEO at NMD Pharma | The Org
Management — NMD Pharma
Company Presentation
Management — NMD Pharma
Management — NMD Pharma
